Frontiers in Cardiovascular Medicine

MARCH 6, 2025

BackgroundCoronary heart disease (CHD) is a pervasive chronic condition that poses a significant threat to global health and mortality worldwide. This program was tailored to each patient, with a 50% power intensity exercise prescription derived from the results of the patient's Cardiopulmonary Exercise Testing (CPET) evaluation.

Cardiac Function 52

Cardiac Function Exercise Heart Disease Ischemia 52

Heart BMJ

AUGUST 26, 2024

LEARNING OBJECTIVES Review the diagnostic pathway for pulmonary arterial hypertension (PAH) in congenital heart disease (CHD). Understand and interpret right heart catheterisation data in pulmonary hypertension related to CHD. Recognise the typical presentation of PAH in patients with CHD.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Pulmonary Hypertension 52

Science Daily - Heart Disease

DECEMBER 13, 2023

Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary arterial hypertension, a form of high blood pressure that occurs in the blood vessels of the lungs and typically affects middle-aged women, according to a new study.

Pulmonary 113

Pulmonary Hypertension Blood Pressure 113

Open Heart

DECEMBER 14, 2023

Objective To determine the magnitude of any excess risk of mortality and hospitalisation due to COVID-19 infection in patients with congenital heart disease (CHD) in the UK healthcare system. Of patients with a positive COVID-19 test, patients with CHD were more likely than controls to be hospitalised (22.4%

COVID-19 98

COVID-19 Congenital Heart Disease Congenital Heart Disease 98

Frontiers in Cardiovascular Medicine

JANUARY 13, 2025

Valvular heart disease (VHD) leading to inadequate hemodynamic circulation is a major cause of cardiovascular morbidity and mortality worldwide. Right ventricular-pulmonary artery (RVPA) coupling integrates the ability of RV contractility to adapt to increased pulmonary arterial afterload.

Pulmonary 52

Pulmonary Heart Disease Circulation Outcomes 52

Heart BMJ

MARCH 13, 2025

Historically viewed as a secondary consequence of left-sided heart disease or pulmonary hypertension, its pathophysiology and prognostic implications have garnered attention in recent years. Severe TR has been independently associated with increased mortality, regardless of left ventricular (LV) function or pulmonary pressures.

Tricuspid 52

Tricuspid Pulmonary Article Heart Disease 52

Journal of Cardiothoracic Surgery

JUNE 26, 2024

Pulmonary arteriovenous fistula (PAVF) is a rare disease, and its symptoms lack specificity. For patients with coronary heart disease(CHD), hypertension and other common cardiovascular diseases, PAVF is easy t.

Heart Disease 52

Heart Disease Pulmonary Cardiovascular Disease Hypertension 52

Journal of the American Heart Association

JANUARY 9, 2025

Journal of the American Heart Association, Ahead of Print. Survivorship from congenital heart disease has improved rapidly secondary to advances in surgical and medical management. This is an updated report of the American Heart Association's previous publications on exercise in children.

Congenital Heart Disease 75

Congenital Heart Disease Congenital Exercise Heart Disease 75

American College of Cardiology

FEBRUARY 25, 2025

William Boden and Bradley Maron discuss the latest advancements in managing pulmonary hypertension caused by left heart disease. In this interview, Drs.

Heart Disease 49

Heart Disease Pulmonary Hypertension Article 49

Journal of the American Heart Association

JANUARY 17, 2025

However, the cause and risk factors for mortality remain uncertain.MethodsThis retrospective, singlecenter study identified children with primary and secondary pulmonary vein stenosis through a cardiac catheterization database. P=0.032), and the presence of congenital heart disease (HR, 2.4 [95% 95% CI, 2.214.1];P<0.001).

Stenosis 76

Stenosis Pulmonary Sudden Cardiac Death Pediatrics 76

All About Cardiovascular System and Disorders

APRIL 17, 2024

Tetralogy of Fallot TOF with pulmonary atresia Pulmonary atresia with intact interventricular septum Tricuspid atresia Double outlet right ventricle Transposition of great arteries with ventricular septal defect and pulmonary stenosis Ebstein’s anomaly of tricuspid valve In DORV and tricuspid atresia, there are also variants with increased pulmonary (..)

Congenital Heart Disease 52

Congenital Heart Disease Pulmonary Tricuspid Congenital 52

All About Cardiovascular System and Disorders

APRIL 17, 2024

D-Transposition of great arteries Double outlet right ventricle without pulmonary pulmonary stenosis Taussig-Bing anomaly Total anomalous pulmonary venous return Truncus arteriosus Single ventricle (double inlet ventricle, univentricular heart)

Congenital Heart Disease 52

Congenital Heart Disease Pulmonary Congenital Heart Disease 52

Journal of the American Heart Association

SEPTEMBER 12, 2024

Due to improvements in recognition and management of their multisystem disease, the long‐term survival of infants, children, and adolescents with trisomy 21 and congenital heart disease now matches children with congenital heart disease and no genetic condition in many scenarios.

Congenital Heart Disease 71

Congenital Heart Disease Congenital Heart Disease Quality of Life 71

Frontiers in Cardiovascular Medicine

FEBRUARY 13, 2025

Specific cardiovascular diseases, such as acute myocardial infarction, arrhythmias, pulmonary hypertension and pericarditis, were also pointed.

Myocardial Infarction 52

Myocardial Infarction Biomarkers Pericarditis Cardiovascular Disease 52

HeartRhythm

APRIL 30, 2024

Transcatheter pulmonary valve replacement (TPVR) has become a safe and effective alternative to surgical PVR in tetralogy of Fallot (TOF), isolated pulmonary stenosis (PS), and other congenital heart disease (CHD) variants.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Arrhythmia Pulmonary 40

Frontiers in Cardiovascular Medicine

MAY 8, 2024

Patients with pulmonary hypertension associated with a left-right shunt include a wide spectrum of pathophysiological substrates, ranging from those characterized by pulmonary over-circulation to those with advanced pulmonary vascular disease.

Congenital Heart Disease 52

Congenital Heart Disease Pulmonary Hypertension Congenital 52

Frontiers in Cardiovascular Medicine

FEBRUARY 2, 2024

Aims A proportion of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) do not fit in the current classification.

Congenital Heart Disease 64

Congenital Heart Disease Congenital Pulmonary Hypertension 64

Heart BMJ

FEBRUARY 12, 2024

Pulmonary arterial hypertension related to congenital heart disease as a paradigm of complexity Pulmonary arterial hypertension related to congenital heart disease (PAH-CHD) really represents a paradigm of complexity.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Pulmonary Heart Disease 40

Journal of Cardiothoracic Surgery

MAY 10, 2024

Total anomalous pulmonary venous connection (TAPVC) is a rare congenital heart disease characterized by the inability of all pulmonary veins to connect to the left atrium. Our previous bibliometric article sum.

Pulmonary 52

Pulmonary Congenital Heart Disease Congenital Research 52

Science Daily - Heart Disease

JANUARY 2, 2024

Higher levels of omega-3, the healthy fat found in fish and nuts, were associated with better lung function and longer transplant-free survival.

Pulmonary 115

Pulmonary Transplant 115

Frontiers in Cardiovascular Medicine

JANUARY 14, 2024

Its use has been approved in the adult population with heart failure and described for pulmonary hypertension (PH). Only case reports and small series have been published about its use in the paediatric population and for congenital heart disease (CHD).

Congenital Heart Disease 59

Congenital Heart Disease Cardiomyopathy Congenital Heart Disease 59

Journal of Cardiothoracic Surgery

JANUARY 22, 2024

The left partial anomalous pulmonary vein connection is a rare congenital heart disease, especially with intact atrial septum. Now we reported a case of the left superior pulmonary vein drainage to left innomi.

Pulmonary 52

Pulmonary Congenital Heart Disease Congenital Heart Disease 52

Journal of the American Heart Association

NOVEMBER 28, 2023

Transpulmonary exosomal miRs offer valuable insights into pulmonary circulation microenvironments. Using an in vitro flow model simulating the shear stress experienced by pulmonary endothelial cells, we observed a significant upregulation of miR‐21.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Pulmonary Heart Disease 40

Open Heart

SEPTEMBER 13, 2024

Background To determine the frequency of pregnancy complications and their association with the risk of cardiovascular outcomes in women with structural heart disease (SHD).

Heart Disease 52

Heart Disease Congenital Heart Disease Congenital Hypertension 52

Heart BMJ

FEBRUARY 12, 2024

Objective This study assessed the long-term effects of triple therapy with prostanoids on patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD), as there is limited information on the safety and efficacy of this treatment approach.

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

Circulation: Cardiovascular Interventions

NOVEMBER 6, 2023

Background:Neonates with complex congenital heart disease and pulmonary overcirculation have been historically treated surgically. Pulmonary arteries grew adequately for age, and devices were easily removed without complications. However, subcohorts may benefit from less invasive procedures. At a median follow-up of 6.2

Congenital Heart Disease 40

Congenital Heart Disease Congenital Heart Disease Pulmonary 40

DAIC

JUNE 4, 2024

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Scientists Suggest a New Method for Diagnosing Heart Diseases 6. Weight Loss Drug Linked with Reduced Need for Diuretics in Heart Failure Patients 7. Tenax Therapeutics Announces New U.S.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

Frontiers in Cardiovascular Medicine

JANUARY 11, 2024

Objective Early risk assessment of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) is crucial to ensure timely treatment. Class Activation Mapping (CAM) images demonstrated the model's attention focused on the pulmonary artery segment.

VSD 59

VSD Pulmonary Congenital Heart Disease Congenital 59

Frontiers in Cardiovascular Medicine

JULY 5, 2024

IntroductionPrimary pulmonary vein stenosis (PVS) is a rare congenital heart disease that proves to be a clinical challenge due to the rapidly progressive disease course and high rates of treatment complications. These 3D reconstructions were 3D printed using a clear resin ink and used in a benchtop experimental setup.

Stenosis 52

Stenosis Pulmonary Congenital Heart Disease Stents 52

Circulation

NOVEMBER 11, 2024

Animal studies have shown that mice with TBX1 gene mutations have smaller left pulmonary arteries compared to wild type mice, defined by a reduced left pulmonary artery (LPA) to right pulmonary artery (RPA) ratio. A single study has shown this translates to humans with 22q11 and structurally normal hearts.

Pulmonary 40

Pulmonary Risk Factors Heart Disease Echocardiogram 40

Science Daily - Heart Disease

JANUARY 22, 2025

A new molecular imaging technique -- 18F-FAPI PET -- can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing physicians with an early marker for disease progression.

Pulmonary 52

Pulmonary Hypertension 52

Journal of the American Heart Association

NOVEMBER 28, 2023

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundLeft heart disease is the most common cause of pulmonary hypertension (PH) and is frequently accompanied by increases in pulmonary vascular resistance.

Pulmonary 40

Pulmonary Atrial Fibrillation Hypertension Heart Disease 40

All About Cardiovascular System and Disorders

APRIL 8, 2024

Sudden breathlessness at night in those with known heart disease is usually due to collection of fluid in the lungs (pulmonary edema). Extra fluid in the body can occur due to failure of heart, kidneys, liver and rarely due to other causes.

Heart Disease 52

Heart Disease Bicuspid/Mitral Heart Failure Stenosis 52

American College of Cardiology

DECEMBER 19, 2023

This year saw exciting developments in the treatment of pediatric and congenital heart disease. Transcatheter pulmonary valve replacement (TPVR) continued to dominate the field of interventional cardiology.

Congenital 70

Congenital Pediatrics Congenital Heart Disease Interventional Cardiology 70

All About Cardiovascular System and Disorders

APRIL 17, 2024

Atrial septal defect – Ostium Primum, Ostium Secundum, Sinus Venosus Partial anomalous pulmonary venous return Atrioventricular septal defect Ventricular septal defect – inlet, outlet, perimembranous, muscular Patent ductus arteriosus Aortopulmonary window Coronary artery fistula draining to right heart Ruptured sinus of Valsalva aneurysm (..)

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Aneurysm 52

Science Daily - Heart Disease

SEPTEMBER 10, 2024

A scientific team has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease (COPD).

Pulmonary 112

Pulmonary 112

American College of Cardiology

OCTOBER 31, 2024

Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD). Early management of this condition is typically dictated by the degree of pulmonary stenosis (PS) and resulting oxygen saturations.

Congenital Heart Disease 61

Congenital Heart Disease Congenital Stenosis Pulmonary 61